Newsletters

Hadasit Newsletter – July 2020

INNOVATION SPOTLIGHT

COVID-19 Innovation

The last few months have changed the world. Hadasit would like to express our sincere appreciation to Hadassah physicians, nurses, researchers and management for their activities and devotion in fighting the COVID-19 pandemic.

Over the last few months, we filed close to 10 new patent applications dealing with smart diagnostics, treatment, immunization, and protection related to COVID-19. We also signed numerous agreements with industrial partners to bring these developments to the market and financed grants to develop the most promising ideas.

We look forward to continuing our hard work and contributing to the fight against COVID-19.

Your Partner,
The Hadasit Team

Hadassah Accelerator Teams with CBG

Hadassah Accelerator Teams with CBG

Hadassah Accelerator is pleased to welcome a new strategic partner – investment powerhouse Consensus Business Group (CBG) led by businessman Vincent Tchenguiz. The collaboration was announced last month during the Class #2 Demo Day.

With a net asset value of over £1 billion, CBG is one of the UK’s leading family offices, whose overall portfolio includes pharma, biotech, med-tech, cleantech, real estate and other business interests. They have invested more than $400 million in Israel in direct investments and as an LP or GP in incubators and funds from early to late stage investments. CBG is also a leading shareholder and investor in various holdings and platforms, including Hadasit Bio Holdings (“HBL”), Xenia Venture Capital, Capital Nature Group and Trendlines.

As we join together with Hadassah, IBM Alpha Zone, CBG, the Jerusalem Development Authority (JDA) and additional partners, we encourage young, early stage digital health companies to join Hadassah Accelerator Class #3.

To register:

https://www.ibmalphazone.com/hadassahaccelerator/

Hadasit Portfolio Company eDAS Wins IIA COVID-19 Grant

Hadasit Portfolio Company eDAS Wins IIA COVID-19 Grant

Based on the research of Prof. Ran Nir-Paz, Hadasit portfolio company eDAS develops digital diagnostic aid solutions for respiratory infectious diseases. Together with Hadassah and Ichilov hospitals, the company won a grant for piloting real-time use of its solution for remote diagnosis of COVID-19 in a year-long research project with a budget of NIS 1M. The company has made great progress this year and is gearing up for commercial pilots with HMOs in Israel and Europe.

Nobio Hits the Market, Quickly Developing New Anti-Viral Products

Nobio Hits the Market, Quickly Developing New Anti-Viral Products

Nobio was founded in 2015, based on IP developed at Hadassah and the Hebrew University by Prof. Ervin Weiss, Prof. Avi Domb and Dr. Michelle Peretz-Davidi. Their core technology is an anti-microbial nanoparticles coating for multiple uses.

Late in 2019, Nobio received FDA clearance for its first line of products in the dental field. The core activity reached initial sales, which resulted in first royalties to Hadassah. With the COVID-19 outbreak, the company shifted focus, using their technology for new products that provide solutions to the pandemic.

In March, the company signed a collaboration agreement with Supergum to rapidly prototype and test an antiviral protective mask, combining Nobio’s revolutionary antimicrobial technology and Supergum’s market leading CBRN (chemical, biological, radiological and nuclear) breathing protection products.

In April, Nobio was awarded a $205,000 grant from the IIA to rapidly develop personal protection equipment (PPE) and surface coating with long-acting, universal protection, to prevent the transmission of pathogenic microorganisms, such as COVID-19.

LifeCan Medical Spins Off, Developing New Cost-Effective Ventilators

LifeCan Medical Spins Off, Developing New Cost-Effective Ventilators

LifeCan Medical Ltd. has developed a new ventilator that provides cost-effective, mechanical ventilation for a wide range of clinical settings, for immediate and widescale deployment. Invented by Dr. Elchanan Fried, the ventilator helps address the acute global shortage of ventilators highlighted by the coronavirus pandemic.

Highly portable, LifeCan provides a readily-available ventilation solution capable of extended operation at a stable and accurate frequency and volume, according to pre-defined parameters. The device features preset rate/tidal volume, built-in air pressure sensors, failure indicator, and a backup battery.

The company reached an agreement with Elbit Systems for production of 3,000 ventilators, and already has a distribution agreement with Medigus to launch the product in Mexico.

Novel COVID-19 Detection Kit Used by Brazilian and Israeli Companies

Novel COVID-19 Detection Kit Used by Brazilian and Israeli Companies

A novel ELISA test for detecting SARS-CoV-2 (the new coronavirus causing COVID-19) antibodies in patients’ blood has been developed by Prof. Dana Wolf of Hadassah, together with colleagues from the Hebrew University of Jerusalem Faculty of Medicine. Hadasit and Yissum executed two royalty-bearing license agreements with an Israeli and a Brazilian company to commercialize the kit, each in separate territories.

The test allows for differentiation between individuals that have been exposed to SARS-CoV-2 and naïve (unexposed) individuals. In addition to diagnosing recent and past infections, the test kit can assist healthcare systems in assessing population exposure rate and immunity, as well as in planning public health strategies.

Collaboration with Ximbio

Collaboration with Ximbio

We are delighted to announce our new partnership with Ximbio, a global research reagents distribution company (https://ximbio.com). Ximbio provides Hadassah-made reagents under a revenue share agreement. Our BR45, and BR98 cell lines, developed by Prof. Tamar Yablonski-Peretz and her team, were derived from triple negative breast cancer and ovarian cancer patients. The unique lines can serve as a platform for drug screening for cancer cells or for cancer stem cell targeted compounds in vitro and in vivo. More information can be found at https://lnkd.in/gakXt-N.

© 2020 Hadasit, All rights reserved.
www.hadasit.org.il